AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+4%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.6B
AUM Growth
+$284M
(+2.8%)
Cap. Flow
+$38M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
48.98%
Holding
1,222
New
192
Increased
357
Reduced
489
Closed
182
Top Buys
| 1 |
Delek Logistics
DKL
|
$63.8M |
| 2 |
Marsh & McLennan
MMC
|
$21.1M |
| 3 |
T Rowe Price
TROW
|
$18.4M |
| 4 |
S&P Global
SPGI
|
$18.2M |
| 5 |
Cheniere Energy
CQP
|
$18M |
Top Sells
| 1 |
Hess Midstream
HESM
|
$35.4M |
| 2 |
Plains All American Pipeline
PAA
|
$20.8M |
| 3 |
First Solar
FSLR
|
$20M |
| 4 |
Lockheed Martin
LMT
|
$17.4M |
| 5 |
Cameco
CCJ
|
$16.1M |
Sector Composition
| 1 | Energy | 62.63% |
| 2 | Technology | 6.2% |
| 3 | Consumer Discretionary | 4.28% |
| 4 | Healthcare | 4.08% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Range Resources
RRC
$8.27B
| $254K | ﹤0.01% |
+10,074
| New | +$254K |
|
|
SKE
977
Skeena Resources
SKE
$1.99B
| $254K | ﹤0.01% |
54,239
+8,577
| +19% | +$40.2K |
|
978
Charter Communications
CHTR
$35.7B
| $249K | ﹤0.01% |
+821
| New | +$249K |
|
|
CMPS
979
Compass Pathways
CMPS
$493M
| $249K | ﹤0.01% |
23,178
-2,038
| -8% | -$21.9K |
|
980
SIGA Technologies
SIGA
$603M
| $245K | ﹤0.01% |
+23,759
| New | +$245K |
|
981
Antero Resources
AR
$10.1B
| $243K | ﹤0.01% |
+7,946
| New | +$243K |
|
|
AMRN
982
Amarin Corp
AMRN
$317M
| $240K | ﹤0.01% |
11,000
-776
| -7% | -$16.9K |
|
|
SBOW
983
DELISTED
SilverBow Resources, Inc.
SBOW
| $235K | ﹤0.01% |
+8,748
| New | +$235K |
|
984
C4 Therapeutics
CCCC
$194M
| $234K | ﹤0.01% |
26,696
-2,254
| -8% | -$19.8K |
|
985
Organogenesis Holdings
ORGO
$634M
| $231K | ﹤0.01% |
71,410
-5,190
| -7% | -$16.8K |
|
986
Protagonist Therapeutics
PTGX
$3.77B
| $226K | ﹤0.01% |
26,821
-2,048
| -7% | -$17.3K |
|
|
ICPT
987
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $226K | ﹤0.01% |
16,229
-1,404
| -8% | -$19.6K |
|
988
Cigna
CI
$81.5B
| $225K | ﹤0.01% |
812
-91
| -10% | -$25.2K |
|
989
Alto Ingredients
ALTO
$90.6M
| $224K | ﹤0.01% |
+61,600
| New | +$224K |
|
990
Chemours
CC
$2.34B
| $224K | ﹤0.01% |
+9,084
| New | +$224K |
|
991
Travelers Companies
TRV
$62B
| $224K | ﹤0.01% |
1,464
-124
| -8% | -$19K |
|
992
HCA Healthcare
HCA
$98.5B
| $221K | ﹤0.01% |
1,200
-101
| -8% | -$18.6K |
|
993
Kodiak Sciences
KOD
$556M
| $220K | ﹤0.01% |
28,362
-2,456
| -8% | -$19.1K |
|
994
Tootsie Roll Industries
TR
$2.97B
| $219K | ﹤0.01% |
7,202
-10,129
| -58% | -$308K |
|
995
Intercontinental Exchange
ICE
$99.8B
| $217K | ﹤0.01% |
+2,403
| New | +$217K |
|
996
Delta Air Lines
DAL
$39.9B
| $216K | ﹤0.01% |
+7,680
| New | +$216K |
|
997
Arcturus Therapeutics
ARCT
$485M
| $215K | ﹤0.01% |
14,481
-1,196
| -8% | -$17.8K |
|
998
ALX Oncology
ALXO
$65.3M
| $213K | ﹤0.01% |
22,254
-1,876
| -8% | -$18K |
|
999
Alcoa
AA
$8.24B
| $212K | ﹤0.01% |
6,300
+1,584
| +34% | +$53.3K |
|
1000
Ocugen
OCGN
$322M
| $210K | ﹤0.01% |
118,230
-9,700
| -8% | -$17.2K |
|